$1.79
2.19% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
CA88338H1001
Symbol
THTX
Sector
Industry

Theratechnologies Inc. Stock price

$1.79
+0.61 51.69% 1M
+0.40 28.78% 6M
+0.17 10.49% YTD
+0.19 11.88% 1Y
-10.01 84.83% 3Y
-10.11 84.96% 5Y
+0.57 47.01% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.04 2.19%
ISIN
CA88338H1001
Symbol
THTX
Sector
Industry

Key metrics

Market capitalization $43.32m
Enterprise Value $62.29m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.74
P/S ratio (TTM) P/S ratio 0.51
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 5.75%
Revenue (TTM) Revenue $84.32m
EBIT (operating result TTM) EBIT $11.57m
Free Cash Flow (TTM) Free Cash Flow $-1.66m
Cash position $38.86m
EPS (TTM) EPS $-0.09
P/E forward 51.14
P/S forward 0.52
EV/Sales forward 0.74
Short interest 0.10%
Show more

Is Theratechnologies Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Theratechnologies Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Theratechnologies Inc. forecast:

3x Buy
75%
1x Hold
25%

Analyst Opinions

4 Analysts have issued a Theratechnologies Inc. forecast:

Buy
75%
Hold
25%

Financial data from Theratechnologies Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Aug '24
+/-
%
84 84
6% 6%
100%
- Direct Costs 21 21
12% 12%
25%
63 63
14% 14%
75%
- Selling and Administrative Expenses 33 33
8% 8%
39%
- Research and Development Expense 16 16
55% 55%
19%
14 14
195% 195%
17%
- Depreciation and Amortization 2.84 2.84
23% 23%
3%
EBIT (Operating Income) EBIT 12 12
162% 162%
14%
Net Profit -3.16 -3.16
89% 89%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about Theratechnologies Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Theratechnologies Inc. Stock News

Neutral
GlobeNewsWire
10 days ago
MONTREAL, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the Company has submitted a Prior Approval Supplement (PAS) to the U.S. Food and Drug Administration (FDA) describing the changes made to the ...
Neutral
GlobeNewsWire
18 days ago
MONTREAL, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the United States Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) goal date of March 25, 2025 to the ...
Neutral
GlobeNewsWire
20 days ago
No dose-limiting toxicities reported in two different weekly doses in heavily pre-treated patients Preliminary evidence of dose response includes significant tumor shrinkage and one patient with complete resolution of a liver lesion MONTREAL, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Thera technologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company foc...
More Theratechnologies Inc. News

Company Profile

Theratechnologies, Inc. is a pharmaceutical company. It engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Theratechnologies was founded on October 19, 1993 and is headquartered in Montreal, Canada.

Head office Canada
CEO Paul Lévesque
Employees 114
Founded 1993
Website www.theratech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today